Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Inventory (2020 - 2025)

Neuroone Medical Technologies' Change in Inventory history spans 6 years, with the latest figure at -$560658.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 20.39% year-over-year to -$560658.0; the TTM value through Dec 2025 reached -$254714.0, down 179.05%, while the annual FY2025 figure was -$398348.0, 143.85% down from the prior year.
  • Change in Inventory reached -$560658.0 in Q4 2025 per NMTC's latest filing, down from $331604.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $841721.0 in Q3 2024 to a low of -$704292.0 in Q4 2024.
  • Average Change in Inventory over 5 years is $90220.3, with a median of $164922.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: skyrocketed 3854.2% in 2023, then plummeted 496.71% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $130828.0 in 2021, then surged by 52.12% to $199016.0 in 2022, then crashed by 159.31% to -$118029.0 in 2023, then tumbled by 496.71% to -$704292.0 in 2024, then rose by 20.39% to -$560658.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Change in Inventory are -$560658.0 (Q4 2025), $331604.0 (Q3 2025), and $70594.0 (Q2 2025).